SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...
Morning Overview on MSN
A stem cell sponge could absorb joint pain and shield cartilage
Osteoarthritis is one of the most expensive and disabling conditions in modern medicine, driving joint replacements and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback